Benjamin F. Edwards & Company’s Medifast MED Stock Holding History

Benjamin F. Edwards & Company’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-20	Closed	-$3K	–	1637
2018 Q2	$3K	Buy	+20	New	+$2.56K	﹤0.01%	1486

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Benjamin F. Edwards & Company's MED Position: Q3 2018 in Review

Benjamin F. Edwards & Company sold out of Medifast (MED) in Q3 2018, closing a stake of 20 shares — an estimated $3K sold.

Benjamin F. Edwards & Company first reported a position in MED in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 266 funds tracked by Wall St. Rank hold MED as of Q3 2018.

Benjamin F. Edwards & Company reported no remaining Medifast position as of Q3 2018 after selling out during the quarter.
Benjamin F. Edwards & Company sold 20 Medifast shares in Q3 2018, an estimated $3K.
Benjamin F. Edwards & Company first reported a position in Medifast in Q2 2018 and held it in 1 quarter.
Benjamin F. Edwards & Company's Medifast position peaked at $3K in Q2 2018.
266 funds tracked by Wall St. Rank held Medifast as of Q3 2018.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2018, filed 29 Oct 2018.